CLIK
You are here
Yttrium therapy
Fibrosing interstitial lung disease - Yttrium therapy Factor
Last reviewed for CCPS 16 December 2009.
Preliminary questions [40667]
40686 there is some evidence that yttrium-90 microspheres as therapy may be a factor in the development or worsening of the condition under consideration.
40994 the veteran has received yttrium-90 microspheres as therapy at some time.
40995 the veteran received yttrium-90 microspheres as therapy for primary and metastatic liver tumours. 40996 — the veteran received yttrium-90 microspheres as therapy for treatment of an illness or injury which is identifiable. 40999 — the veteran has established the causal connection between yttrium-90 microspheres as therapy and VEA service for fibrosing interstitial lung disease. 41000 — the veteran has established the causal connection between yttrium-90 microspheres as therapy and VEA service for the clinical onset of fibrosing interstitial lung disease. 41002 — the veteran has established the causal connection between yttrium-90 microspheres as therapy and operational service for the clinical onset of fibrosing interstitial lung disease. or 41003 — the veteran has established the causal connection between yttrium-90 microspheres as therapy and eligible service for the clinical onset of fibrosing interstitial lung disease. or 41001 — the veteran has established the causal connection between yttrium-90 microspheres as therapy and VEA service for the clinical worsening of fibrosing interstitial lung disease. 41004 — the veteran has established the causal connection between yttrium-90 microspheres as therapy and operational service for the clinical worsening of fibrosing interstitial lung disease. or 41005 — the veteran has established the causal connection between yttrium-90 microspheres as therapy and eligible service for the clinical worsening of fibrosing interstitial lung disease. Clinical onset and operational service [41002] 41006 — the identified illness or injury, for which the veteran received yttrium-90 microspheres as therapy, is causally related to operational service. Clinical onset and eligible service [41003] 41007 — the identified illness or injury, for which the veteran received yttrium-90 microspheres as therapy, is causally related to eligible service. Clinical worsening and operational service [41004] 41006 — the identified illness or injury, for which the veteran received yttrium-90 microspheres as therapy, is causally related to operational service. Clinical worsening and eligible service [41005] 41007 — the identified illness or injury, for which the veteran received yttrium-90 microspheres as therapy, is causally related to eligible service.